Diploma in Clinical Cardiology Part 3/3

Name: Diploma in Clinical Cardiology Part 3/3
Rating: 4.7 (9 reviews)

Advance Cardiology with ECG, Echocardiography, Pacemaker, Rhythm management and Electrophysiology

Created byHeartbeatsZ Academy, UK

Last updated 3/2026

English

What you'll learn

Electrophysiology
Echocardiography
Cardiac emergency
Cardiac subspecialities

Course content

6 sections • 48 lectures • 21h 27m total length

Infective endocarditis - clinical case, MCQs and inisghts19:28
Cardiac Cycle Mastery: From Diastole to Systole & Beyond24:54
Master the complete cardiac cycle with detailed physiological explanations. Learn how atrial and ventricular contractions generate blood flow.

Key Topics: Diastole phases, systolic function, pressure-volume dynamics, heart sounds, and ECG correlations for clinical practice.

Objectives: Understand hemodynamics, apply knowledge to patient assessment, and recognize pathological variations in rhythm.
2025 AHA Hypertension Guidelines: Latest Updates & Clinical Management Strategie1:02:36
Master the 2025 AHA Hypertension Guidelines covering prevention, detection, and evidence-based management strategies for clinical practice.

Blood Pressure Classification: Learn diagnostic criteria and standardized measurement techniques for accurate screening and diagnosis.

Management Approach: Explore lifestyle modifications, pharmacotherapy, and patient-specific strategies for different populations including diabetes and cardiovascular disease.
Valsalva Maneuver for SVT: Proven Techniques to Terminate Supraventricular Tachy4:55
Master the Valsalva maneuver technique for terminating supraventricular tachycardia. Learn proper patient positioning and breathing mechanics.

Technical Execution: Step-by-step instruction on correct force application, duration, and position changes during the maneuver.

Clinical Efficacy: Understand success rates, timing in SVT management, and integration with pharmacological interventions for optimal outcomes.
Cardiac Electrical System Explained: From SA Node to Ventricular Depolarization0:53
Understand the cardiac electrical system including SA node, AV node, Bundle of His, and Purkinje fibers for proper electrical conduction.

Conduction Pathway: Learn the sequential atrial and ventricular activation, refractory periods, and action potential mechanisms.

Clinical Correlation: Explore ECG interpretation, arrhythmia mechanisms, and pathological conduction abnormalities.
Cardiac Medication Complications: Side Effects & Drug Interactions You Must Know4:39
Examine adverse effects and drug interactions of common cardiac medications including ACE inhibitors, beta-blockers, and diuretics.

Side Effect Management: Learn recognition of toxicity, monitoring parameters, and patient counseling strategies for safe therapy.

Drug Interactions: Understand CYP interactions, dosing adjustments, and management of polypharmacy in cardiac patients.
Regulatory Authorities in Healthcare: FDA Approval, Compliance & Drug Safety Sta4:29
Understand FDA regulatory framework, drug approval pathways (IND, NDA, BLA), and post-market surveillance for cardiac medications.

Compliance Standards: Learn Good Manufacturing Practice (GMP), regulatory documentation, and quality assurance in pharmaceutical development.

Patient Safety: Explore adverse event reporting, pharmacovigilance, and regulatory enforcement mechanisms protecting public health.
Artificial Intelligence in Cardiology: Machine Learning Applications & Clinical10:51
Explore artificial intelligence, machine learning, and deep learning applications in cardiac imaging, risk prediction, and diagnosis.

Clinical AI Tools: Learn about ECG analysis algorithms, echocardiography interpretation, and coronary disease detection using AI technology.

Future of Cardiology: Understand limitations, validation challenges, and ethical considerations in implementing AI systems in clinical practice.
Electrolyte Disturbances in Heart Failure: Hyperkalemia, Hyponatremia & Clinical2:37
Master management of hyperkalemia, hyponatremia, and other electrolyte abnormalities in acute decompensated heart failure patients.

Pathophysiology: Learn mechanisms of electrolyte disturbances, fluid retention, and compensation in heart failure conditions.

Treatment Protocols: Understand diuretic therapy, RAAS inhibitors, SGLT2 inhibitors, and emergency intervention for critical electrolyte imbalances.
Understanding Cardiac Tamponade_ Symptoms, Diagnosis, and Treatment2:10
Cardiology and Longevity – What Really Extends Life Expectancy in Your Patients4:27
→ Diabetes in Cardiology – Choosing and Adjusting Medications for Heart Protecti32:50
Documentation that Protects You – Medicolegal‑Safe Cardiology in Busy Clinic4:27
Why Arrhythmias Happen – Mechanisms That Simplify ECG Interpretation3:42
Paediatric Cardiology in a Hurry – Real Cases That Change How You Think1:07:06
Pediatric Cardiology Case Studies and Diagnoses - presents a series of case studies and diagnostic questions encountered in pediatric cardiology. Each entry typically includes a clinical scenario, imaging or physiological data like echocardiogram findings, ECG results, catheterization pressures and saturations, or chest X-ray descriptions. The questions prompt the reader to identify diagnoses, relevant views or structures, potential differential diagnoses, ECG findings associated with specific conditions, and expected physiological or radiographic features. Conditions range from congenital heart defects like interrupted aortic arch and transposition of the great vessels to acquired conditions and specific findings like a supramitral ring or ruptured sinus of Valsalva. The overarching purpose is likely educational, testing knowledge of various cardiac anomalies and their diagnostic workup in newborns, infants, and children. The lecture primarily focusing on cardiovascular anomalies identified through chest X-rays and in one instance, a CT scan. Each case describes a young patient with specific clinical symptoms, followed by radiographic findings indicative of congenital heart defects. Conditions such as transposition of the great vessels, corrected transposition, tricuspid atresia, Ebstein's anomaly, total anomalous pulmonary venous connection, Scimitar syndrome, and a vascular ring are illustrated. The descriptions highlight key radiological features like cardiomegaly, altered pulmonary vascular markings, and characteristic structural abnormalities. These notes serve as a visual and diagnostic guide for recognizing different congenital cardiac conditions in children.

ESC 2021 in One Sitting – Rapid High‑Yield Revision for Exams and Ward Rounds0:48
Resuscitation 2025 – What Actually Changed and How It Affects Your Next Arrest44:34
Heart Failure Updates – A Conversational Deep‑Dive into Modern Diagnosis39:10
2024 AHA Stroke Primary prevention Guidelines16:21
2025 ACC/AHA Acute Coronary Syndromes Management Guideline34:24
❤️‍? 2025 ACC/AHA Acute Coronary Syndromes Management Guideline addresses the management of patients with acute coronary syndromes (ACS). It provides recommendations for diagnosis, treatment strategies (both medical and interventional), and long-term management, incorporating the latest evidence-based methodologies. The guideline covers various aspects, including risk stratification, reperfusion strategies, medication use, and cardiac rehabilitation. Specific sections focus on STEMI, NSTE-ACS, and complications like cardiogenic shock and arrhythmias. It also emphasizes patient education, discharge planning, and addresses knowledge gaps for future research. The document aims to improve cardiovascular care quality and align with patient interests, replacing previous guidelines on the topic
A Stepwise Approach to Prescribing Novel Lipid-Lowering Medications5:21

Introduction to Clinical Cardiology. Modern Applications and Practical Examples12:58
Cardiac Embryology Demystified – The Simple Patterns Behind Complex Defects6:34
Reading the Chest for the Heart – Cardiac Anatomy on X‑ray and CT7:20
Master Clinical Cardiology_ Uncover the Heart's Mysteries2:51
→ Novel Lipid‑Lowering Drugs – A Simple Stepwise Prescribing Blueprint1:21:13
Timestamp, Slide Content Summary

00:00 - 01:05,Title and Introduction: Overview of NICE NG238 and AAC Lipid Pathways; speaker bio for Prof. Narendra Kumar.
01:06 - 01:32,"Session Objectives: Risk Assessment, Treatment Optimization (Statins/Newer Agents), and Lifestyle Adherence."
01:33 - 03:15,Evidence-Based Remission: Concepts of reversing chronic conditions like T2D through intensive lifestyle/medical intervention.
03:16 - 05:01,The Twin Cycle Hypothesis: How liver/pancreatic fat drives metabolic disease and the global health economic context of lipid drugs.
05:02 - 07:45,QRISK3 and Non-Fasting Lipids: The shift toward non-fasting blood tests and the specific limitations/underestimations of QRISK3.
07:46 - 10:12,"High-Risk Special Groups: Identifying patients (T1D, CKD, Clinical CVD) who bypass QRISK scoring for immediate treatment." 10:13 - 12:30,"Life-Course Risk: The ""Area Under the Curve"" concept—cumulative LDL exposure over decades vs. late-life intervention."
12:31 - 15:55,"Familial Hypercholesterolaemia (FH): Identifying FH (TC 7.5, LDL 4.9) and the importance of Simon Broome criteria and cascade testing." 15:56 - 18:20,First-Line Statin Therapy: Dosing standards (Atorvastatin 20mg for Primary vs. 80mg for Secondary Prevention).
18:21 - 21:10,"Baseline Diagnostics: Essential pre-treatment checks: Lipid profile, ALT/AST, eGFR, HbA1c, and CK (if symptomatic)."
21:11 - 25:00,The 40% Non-HDL Goal: Using Non-HDL as the primary metric for success and the logic behind the 3-month follow-up.
25:01 - 28:30,"Statin Intolerance Management: Addressing the Nocebo effect; protocols for ""Statin Challenges"" and switching to Rosuvastatin."
28:31 - 32:15,Ezetimibe (Second-Line): Mechanism of blocking gut absorption and achieving an additional 15-20% LDL reduction.
32:16 - 36:50,Bempedoic Acid (Nilemdo): A pro-drug activated in the liver to avoid muscle symptoms (SAMS) for intolerant patients. 36:51 - 42:29,"The AAC Escalation Hierarchy: Flowchart of adding Ezetimibe, Bempedoic Acid, and then moving to injectable therapies."

42:30 - 49:20,"Inclisiran (siRNA) Overview: The ""twice-yearly"" injection mechanism and the logistics of nurse-led community administration."
49:21 - 53:45,NICE TA733 Eligibility: Criteria for Inclisiran: Secondary prevention patients with persistent LDL 2.6 mmol/L or higher.
53:46 - 57:10,PCSK9 Inhibitor MABs: Review of Alirocumab/Evolocumab for very high-risk and FH populations.
57:11 - 61:30,The Legacy Effect: Data on the 22% reduction in vascular events per 1 mmol/L LDL drop.
61:31 - 65:00,Safety and Side Effects: Managing injection site reactions and confirming lack of liver/muscle toxicity for new agents.
65:01 - 72:15,"Addressing Clinical Inertia: The necessity of rapid combination therapy rather than ""wait and see"" monitoring."
72:16 - 78:40,"Q&A Session: Discussion on practical implementation in primary care, funding, and the ""primary care playbook"" checklist."
78:41 - 81:16,Summary and Closing: Final takeaways on bridging the gap between guidelines and patient adherence. Join this channel to get access to perks:

Advance Your Cardiology Knowledge with Our Expert-Led Course4:15
Metabolic Cardiology – Can We Really Reverse Diabetes and Change Cardiac Risk?22:04
Master the Art of ECG with Our Comprehensive Course2:57
ECG in Congenital HeartDisease by Dr Narendra Kumar54:23
Early Repolarisation vs Danger – Fragmented QRS and Subtle High‑Risk Clues13:29
MI in LBBB – Using Sgarbossa (and Beyond) When the ECG Is “Unreadable”10:35
Antiarrhythmic Drug Guidelines – Choosing Safely in AF, VT and More22:04
Holter Reports That Impress – Turning Raw Data into Clear Clinical Decisions50:39
Ventricular Tachycardia ( VT ) – Localisation Clues & Immediate Management Steps30:19

CRT Follow‑Up with Surface ECG – Simple Checks to Spot Non‑Responders Early25:57
Why CRT Fails – Systematic Review of Non‑Responders and What To Do Next38:30
Pacemaker Troubleshooting – A Structured Approach to Common Problems12:39
TAVI/TAVR Explained – Patient Selection, Procedure Basics, and Complications19:53
Exploring Novel Lipid-Lowering Therapies for Dyslipidemia3:10
Lipoprotein(a) and Beyond – The “Hidden” Risk Factor in Modern Cardiology8:48

Landmark Cardiology Clinical Trials PART 2 - HTN, STEMI, HCM, PAD, DM, AF, CAD,1:03:39
❤️ Landmark Cardiovascular Clinical Trials: Hypertension to Dyslipidemia summarizes numerous landmark clinical trials that have significantly shaped the understanding and treatment of various cardiovascular and metabolic conditions. The trials primarily focus on hypertension, myocardial infarction (STEMI), hypertrophic cardiomyopathy, peripheral arterial disease, diabetes, atrial fibrillation, coronary artery disease, dyslipidemia, and pulmonary hypertension. Each summary typically outlines the trial's objective, key outcomes, and resulting clinical impact, often leading to changes in treatment guidelines. Together, these summaries provide a broad overview of the evidence-based foundations guiding modern cardiology and related fields.
Landmark Cardiology Trials part 1 ARNI, beta-blockers, SGLT2i, FFR, PCI, Vs CABG1:25:05
2025 Cardiovascular Trials – The New Evidence You Will Be Asked About24:04
ACS 2025 in Practice – Integrating Guidelines with Real‑World Constraints40:23
Acute Coronary Syndromes Management Guideline 2025 represents a detailed guideline on the management of acute coronary syndromes (ACS), developed collaboratively by multiple major professional organizations. It serves to update and integrate existing evidence regarding the evaluation and treatment of conditions like ST-elevation myocardial infarction (STEMI) and non-ST-elevation ACS (NSTE-ACS). The guideline outlines methodology and evidence review processes, discusses initial assessments, risk stratification tools, and standard medical therapies. Key areas addressed include reperfusion strategies for STEMI, the approach to NSTE-ACS management, considerations for the catheterization laboratory, cardiogenic shock management, and addressing ACS complications. Furthermore, the document covers in-hospital considerations and provides guidance for discharge planning and secondary prevention, including patient education and cardiac rehabilitation.
Clinical Cases You Will Recognise – Applying Course Learning at the Bedside1:41:55
Clinical Cardiology cases show an overview of various topics in cardiology, covering the causes, clinical presentation, investigations, and treatment of numerous heart conditions. It discusses diseases affecting the heart valves, congenital defects, ischemic heart disease including angina and myocardial infarction, and issues related to the pericardium. The document also explains concepts such as heart failure, systemic and pulmonary hypertension, arrhythmias, and different types of shock, concluding with essential cardiac parameters.
Cardiomyopathies Made Practical – Classifying, Investigating, & Treating Safely1:32:41
?Cardiomyopathies: Types, Diagnosis, and Treatment
?The provided sources offer a comprehensive overview of several cardiomyopathies, beginning with Dilated Cardiomyopathy (DCM), explaining its characteristics, causes (including genetic factors), diagnostic methods like echocardiography and CMR, and treatment approaches.

?It then transitions to Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), detailing its stages, characteristic electrocardiographic findings, and genetic underpinnings involving desmosomal proteins.

?The discussion broadens to include Takotsubo cardiomyopathy (TC), often stress-induced and reversible, and Tachycardia-induced cardiomyopathy, a reversible condition linked to prolonged rapid heart rates.

?Finally, Peripartum cardiomyopathy (PPCM), occurring during or after pregnancy, and Alcoholic Cardiomyopathy, caused by excessive alcohol consumption, are described, emphasizing their clinical presentations, risk factors, and management, often noting their shared features with general heart failure treatments and the importance of genetic evaluation and counseling across various cardiomyopathy types.
Cardiovascular Risk in Diabetes – Building a Stepwise Prevention Strategy58:04
Cardiovascular Risk and Diabetes: A Comprehensive overview presents an overview of the connection between cardiovascular disease and diabetes, particularly Type 2.

It highlights that diabetes significantly increases the risk of various heart-related complications and mortality, illustrating this with statistical data and research findings from studies like the #Framingham Heart Study and #UKPDS

It also addresses the pathophysiology of diabetic complications, including vascular damage and endothelial dysfunction, and provides strategies for managing this elevated risk, encompassing lifestyle modifications like diet and exercise, as well as pharmaceutical interventions for hypertension and dyslipidemia.

Ultimately, the information emphasizes that effective diabetes management is crucial for preventing premature cardiovascular events.

Requirements

Basic understanding of Cardiology and attended Diploma in Clinical Cardiology 1 and 2

Description

Unleash the Power of Cardiology: Master Complex Concepts with Ease!

Are you ready to delve into the fascinating world of Clinical Cardiology ? Look no further! Our cutting-edge course on "Clinical Cardiology " is here to empower you with a comprehensive understanding of these powerful concepts, all while leaving behind the complexities of technical jargon. Get ready to become a top-of-the-class specialist and transform your career like never before!

We welcome you to HeartbeatsZ Academy, a global leader with over 41,000 enrolments from across USA, UK, Germany, Japan, Australia, India etc. and an average rating of 4.3 out of 5 on Udemy. We provide among the best study materials by choosing experts and leaders in the field who are passionate about sharing their knowledge and skills with all. Our global team comprises several clinicians, educationists, managers, and healthcare professionals. We are among the fastest growing healthcare-related academic platforms in a brief span while using the state of art tools such as videos for presentations rather than powerpoint (unless necessary) and AI to make it interesting to our audience since 2016.

At our esteemed institution, we understand that Clinical Cardiology can be intimidating. But fear not! Our expert team of instructors has meticulously designed a course that demystifies this field, presenting the material in an inspiring and approachable manner. Say goodbye to confusion and hello to a newfound confidence in tackling complex concepts.

Imagine the possibilities that lie ahead when you become a master of Clinical Cardiology. Our course will equip you with the knowledge and skills that can truly be a game changer for your career. You'll stand out from the crowd, opening doors to exciting opportunities and propelling your professional growth to unprecedented heights.

What sets our course apart is our unwavering commitment to making Clinical Cardiology accessible to everyone. We've stripped away the unnecessary technical jargon and replaced it with clear, concise explanations that will captivate your interest and ignite your passion for learning. With our inspiring teaching style, you'll not only grasp the material effortlessly but also find joy in the process.

Whether you're a healthcare professional seeking to expand your expertise, a student with a thirst for knowledge, or an individual looking to make a career pivot, our "Cardiac Electrophysiology" course is tailor-made for you. Join us today and embark on a transformative journey where you'll gain a comprehensive understanding of the subject, boost your confidence, and become an invaluable asset in your field.

Don't let the fear of complexity hold you back. Unleash the power of Cardiac Electrophysiology without the intimidation. Enroll in our " Clinical Cardiology" course now and unlock a world of possibilities for your career! Your journey to mastery starts here.

The course planning and execution has taken time for months and years of the technical team and the faculties at Heartbeatsz academy. To do a simple Master review course, the chief faculty had to spend few thousand $ and of course travelling expenses were extra. We aim to share the knowledge in compact way at very affordable price to be able to help our students save money. If you will notice, our faculty are highly qualified across the best academic centers but price wise we have tried to keep more money in your pocket rather than someone else. Moreover, our courses have highest hours of quality video content compared to others surely (please check and compare).

Welcome to Heartbeastz academy course which has been made by experienced researcher and clinician with global reputation and ECES (EHRA Certified Electrophysiology Specialist). He was trained at at the top 50 clinical global university and also at Harvard Medical school for advance medical education.

Who this course is for:

Physician, Nurses, Physiologists, Researchers and Technologists who want to excel in Cardiology.

Diploma in Clinical Cardiology Part 3/3

What you'll learn

Explore related topics

Course content

Section 1: Core Cardiology Foundations – What Every Clinician Must Master15 lectures • 4hr 10min

Latest Cardiology Guidelines – High‑Yield Changes You Must Know6 lectures • 2hr 21min

Clinical Cardiology Essentials – From Anatomy to Bedside Decisions5 lectures • 1hr 51min

ECG and Arrhythmia Mastery – From First Look to Final Diagnosis9 lectures • 3hr 31min

Devices and Structural Interventions – From Pacemakers to TAVI6 lectures • 1hr 49min

Landmark Trials and Real‑World Cases – Evidence That Changes Practice7 lectures • 7hr 46min

Requirements

Description

Who this course is for: